AKT1 and gastric cancer: In gastric cancer, a research has shown that luteolin can suppress the proliferation of MKN45 cells, induce apoptosis, lower the mitochondrial membrane potential, and increase the expression of BAX, Caspase3, and cytochrome C, and reduce the expression of Bcl-2 and p-AKT (69).